SCHEMBL12714432

SCHEMBL12714432

COC(=O)c1ccc(-c2ccc(C)cc2OC)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.58
HPGD P15428 4/20 0.55
ALDH1A1 P00352 4/20 0.55
EGFR P00533 2/20 0.52
LMNA P02545 2/20 0.52
MAPT P10636 5/20 0.49
KDM4E B2RXH2 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
ATM Q13315 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CYP46A1 Q9Y6A2 1/20 0.49
SLC2A1 P11166 1/20 0.48
ERN1 O75460 1/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13066266 0.91 ALDH1A1 (0.58) TDP1HPGDALDH1A1EGFRLMNA
SCHEMBL31238859 0.89 MAPT (0.58) TDP1EGFRLMNAMAPTKDM4E
SCHEMBL12836646 0.84 CA1 (0.61) HPGDALDH1A1EGFRLMNAMAPT
SCHEMBL26571944 0.84 TDP1 (0.61) TDP1HPGDALDH1A1EGFRLMNA
SCHEMBL19111160 0.84 EGFR (0.68) TDP1HPGDALDH1A1EGFRLMNA
SCHEMBL14635301 0.83 MAPT (0.54) HPGDALDH1A1EGFRMAPTKDM4E
SCHEMBL29788226 0.83 MAPT (0.54) HPGDALDH1A1EGFRMAPTKDM4E
SCHEMBL2946107 0.83 PTGS1 (0.55) HPGDALDH1A1EGFRLMNAMAPT
SCHEMBL2952031 0.82 EGFR (0.51) EGFRMAPTKDM4ENPC1RAB9A
SCHEMBL17707305 0.81 TDP1 (0.58) TDP1HPGDALDH1A1EGFRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170037248-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation 2017-02-09 US disclosed
US-9212385-B2 Fluorinated resorufin compounds and their application Life Technologies Corporation (US) 2015-12-15 US disclosed
US-20140220612-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation (US) 2014-08-07 US disclosed
US-20130102014-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation (US) 2013-04-25 US disclosed
US-20110086341-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION Life Technologies Corporation (US) 2011-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110086341-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION CYP2F1, CYP4F2, CYP4F3 TDP1 2299/4885HPGD 649/4885ALDH1A1 162/4885
US-20170037248-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION CYP2F1, CYP4F2, CYP4F3 TDP1 2299/4885HPGD 649/4885ALDH1A1 162/4885
US-20130102014-A1 FLUORINATED RESORUFIN COMPOUNDS AND THEIR APPLICATION CYP2F1, CYP4F2, CYP4F3 TDP1 2299/4885HPGD 649/4885ALDH1A1 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.